Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Mildronate is a structural analog of γ-butyrobetaine (γBB), an intermediate in the biosynthesis of carnitine. It blocks carnitine synthesis by inhibiting γBB hydroxylase (IC50 = 62 µM) and, less potently, carnitine acetyltransferase (Ki = 1.6 mM).1,2,3 Through these actions, mildronate reduces the levels of free carnitine and long chain acyl carnitine.4,5 This leads to suppressed fatty acid metabolism and mitochondrial uncoupling during oxidative conditions, resulting in cardioprotective and neuroprotective effects.4,5,6 Mildronate also improves cognition and reduces amyloid-β pathology in a mouse model of Alzheimer’s disease.7
WARNING This product is not for human or veterinary use.
1. Targeting carnitine biosynthesis: Discovery of new inhibitors against γ-
2. Structural and mechanistic studies on γ-
3. Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism. J. Enzyme Inhib. Med. Chem. 24(6), 1269-1275 (2009).
4. 3-
5. Mildronate, the inhibitor of L-
6. Mildronate and its neuroregulatory mechanisms: Targeting the mitochondria, neuroinflammation, and protein expression. Medicina (Kaunas) 49(7), 301-309 (2013).
7. Mildronate improves cognition and reduces amyloid-
The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila. Nature 538(7623), 109-113 (2016).